Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study

Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study

Abstract Background Hepatitis C virus (HCV)-infected patients with chronic kidney disease (CKD) have rarely been studied because they rarely accept interferon-based therapy (IBT) and have been difficult to follow up. We investigated long-term outcomes of IBT on the population. Methods This populatio...

Full description

Bibliographic Details
Main Authors: Ming-Shyan Lin, Tien-Hsing Chen, Wey-Yil Lin, Chi-Hung Liu, Yung-Yu Hsieh, Wen-Nan Chiu, Chih-Hsiang Chang, Mei-Yen Chen, Chang-Min Chung, Yu-Sheng Lin
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Gastroenterology
Subjects:
Chronic kidney disease
Hepatitis C virus
Hemorrhagic stroke
Pegylated interferon
Online Access:http://link.springer.com/article/10.1186/s12876-017-0653-2

Internet

http://link.springer.com/article/10.1186/s12876-017-0653-2

Similar Items